Abiopharma

🔍 Ravella Satish (Executive)

Company: Zeta Global Holdings Corp. (ZETA)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 6,250 shares of Class A Common Stock at $12.56 per share (Direct)
  Date: 2026-08-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 187,495.00 | transaction_form_type: 4
• Sold 4,329 shares of Class A Common Stock at $28.55 per share (Direct)
  Date: 2026-08-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 183,166.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 25,848 shares of Class A Common Stock (Direct)
  Date: 2026-08-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 157,318.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 6,250 shares of Employee Stock Option (Right to Buy) at $12.56 per share (Derivative)
  Date: 2026-08-12 | Code: M | Expires: 2035-04-24 | equity_swap_involved: 0 | shares_owned_after: 68,750.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Withholding of shares in satisfaction of option exercise costs and withholding taxes due upon the exercise of certain employee stock options.
• F2: Represents a transfer to a trust managed by an independent trustee that was established for trust, estate and tax planning purposes and will also be used to satisfy any tax withholding obligations arising from the vesting of certain restricted stock awards.
• F3: The option vests with respect to 25% of the subject shares on the first anniversary of the grant date. The remainder of the shares vest in twelve equal quarterly installments following the first anniversary of the grant date.